ARTICLE | Company News
Arbor Pharmaceuticals, Eisai sales and marketing update
December 24, 2012 8:00 AM UTC
Eisai divested U.S. rights to its Gliadel Wafer implants to Arbor. The biodegradable polymer implant containing carmustine is approved as an adjunct to surgery and radiation in patients with newly di...